DEHYDROPREGNENOLONE ACETATE
Delorazepam is a longacting benzodiazepine that enhances GABAergic inhibition, providing anxiolytic, sedative, and anticonvulsant effects. Benefits include sustained symptom control in anxiety disorders. Side effects include drowsiness, cognitive slowing, dependence, and withdrawal risk with prolonged use. Only GMP materials will be supplied, logistics all according to GDP.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
Dehydropregnenolone acetate is a stabilized ester of pregnenolone, a neuroactive steroid precursor involved in synthesis of progesterone, glucocorticoids, mineralocorticoids and androgens. It modulates NMDA, GABAA and sigma1 receptors while affecting neuroinflammation and mitochondrial signalling pathways. Esterification enhances stability and controlled release.
Benefits and Advantages
Used in neurosteroidpathway modelling, pregnenoloneconversion studies, neuroinflammation assays, neurocognitive research and steroidogenic enzyme analysis.
Side Effects and Risks
Risks include endocrine disruption, sedation or stimulation (dosedependent), GI irritation and hormonal imbalance. Handle with neurosteroidcompound precautions.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C23H32O3 |
|---|---|
| Molecular Weight | 356.5 g/mol |
| CAS Number | 979-02-2 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | 16-Dehydropregnenolone acetate; 979-02-2; Dehydropregnenolone acetate; 16,17-Didehydropregnenolone acetate; 832VMW7ZGC |
| IUPAC/Chemical Name | [(3S,8R,9S,10R,13S,14S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate |
| InChl Key | MZWRIOUCMXPLKV-RFOVXIPZSA-N |
| InChl Code | InChI=1S/C23H32O3/c1-14(24)19-7-8-20-18-6-5-16-13-17(26-15(2)25)9-11-22(16,3)21(18)10-12-23(19,20)4/h5,7,17-18,20-21H,6,8-13H2,1-4H3/t17-,18-,20-,21-,22-,23+/m0/s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
